Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Circulating Tumor DNA (ctDNA)
100%
Colorectal Cancer
100%
Methylation Status
100%
Prognosis Prediction
100%
SOX11
80%
Methylation
60%
Hazard Ratio
60%
Cysteine Dioxygenase Type 1 (CDO1)
60%
Circulating Tumour DNA Methylation
60%
Postoperative Adjuvant Therapy
60%
Clinical Utility
40%
DNA Methylation Analysis
40%
Independent Prognostic Factor
40%
No Significant Difference
20%
Multivariate Analysis
20%
Plasma Samples
20%
University Hospital
20%
Tumor Suppressor Gene
20%
Prognostic Factors
20%
Subgroup Analysis
20%
Methylation Analysis
20%
Colorectal Cancer Patients
20%
Health Burden
20%
Stage III Colorectal Cancer
20%
DNA Methylation Profiling
20%
Value Case
20%
Medicine and Dentistry
Methylation
100%
Colorectal Carcinoma
100%
Circulating Tumor DNA
100%
Hazard Ratio
33%
Adjuvant Chemotherapy
33%
Prognostic Factor
33%
DNA Methylation
33%
Biological Marker
11%
Tumor Suppressor Gene
11%
Subgroup Analysis
11%
Multivariate Analysis
11%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
Circulating Tumor DNA
100%
DNA Methylation
37%
Methylation Analysis
37%
Multivariate Analysis
12%
Tumor Suppressor Gene
12%
Blood Plasma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Circulating Tumor DNA
100%
Chemotherapy Regimens
60%
Biological Marker
20%
Tumor Suppressor Protein
20%
Immunology and Microbiology
Methylation
100%
Colorectal Carcinoma
100%
DNA Methylation
33%
Blood Plasma
11%
Tumor Suppressor Gene
11%